Raymed Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2025 ,inter alia, to consider and approve Please find the attached Intimation of Board Meeting
Board Meeting Intimation for Meeting Schedule On 05Th November, 2025
Filed with BSE · · 1 page · English
Summary by 6ix AI
Cresanto Global Ltd has announced a board meeting scheduled for early November to discuss financial results. The meeting will focus on the unaudited financial results for the second quarter and half-year period ending in September. Additionally, a limited review report will be considered during this meeting. The company has also indicated a closure period for trading by designated persons prior to the results announcement.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Release
Earlier from Cresanto Global
- Intimation Under Reg. 30 For SEBI (LODR) Regulations, 2015 For Filing Of Petition U/S. 66 Of The Companies Act, 2013
- Cresanto Global Ltd Press Release Oct 28 2025
- Cresanto Global Ltd Press Release Oct 13 2025
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
- Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Later from Cresanto Global
- Board Meeting Outcome for Meeting Schedule On 05Th November, 2025
- Cresanto Global Ltd Press Release Nov 05 2025
- Un-Audited Results For Q2 Ended 30Th September, 2025
- Announcement under Regulation 30 (LODR)-Newspaper Publication
- Cresanto Global Ltd Press Release Nov 07 2025
Follow Cresanto Global into a list and get an email when it puts out news.
Follow Cresanto Global